BRIEF-Celldex’S Metric Study In Metastatic Triple-Negative Breast Cancer Does Not Meet Primary Endpoint

KeepHealthCare.ORG – BRIEF-Celldex’S Metric Study In Metastatic Triple-Negative Breast Cancer Does Not Meet Primary Endpoint April 16 (Reuters) – Celldex Therapeutics Inc: * CELLDEX’S METRIC STUDY IN METASTATIC TRIPLE-NEGATIVE BREAST Continue reading